Export

EN
FR
ATC codes: L01DB02
Indication
Myeloid leukaemia ICD11 code: 2C03.1
INN
Daunorubicin
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection ; 20 mg in vial (as hydrochloride) powder for injection ; 2 mg per mL in vial (as hydrochloride) ; 5 mg per mL in vial (as hydrochloride)
EML status history
First added in 1999 (TRS 895)
Changed in 2002 (TRS 914)
Changed in 2007 (TRS 950)
Changed in 2015 (TRS 994)
Changed in 2023 (TRS 1049)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the addition of additional formulations of daunorubicin (injection 2 mg/mL and 5 mg/mL in vial and powder for injection 20 mg in vial) to the EML and EMLc.